OTC DEFICIENCY

Clinical trials for OTC DEFICIENCY explained in plain language.

Never miss a new study

Get alerted when new OTC DEFICIENCY trials appear

Sign up with your email to follow new studies for OTC DEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 2 Terminated 1

Experimental therapy for rare metabolic disease shows early promise

Disease control Terminated

This study tested a new medicine called ARCT-810 in 8 people aged 12 to 65 with ornithine transcarbamylase (OTC) deficiency, a rare genetic disorder that causes dangerous ammonia buildup. The main goal was to check the drug's safety and how the body processes it. The trial was st…

Matched conditions: OTC DEFICIENCY

Phase: PHASE2 • Sponsor: Arcturus Therapeutics, Inc. • Aim: Disease control

Last updated Jun 27, 2026 07:51 UTC

OTC DEFICIENCY

Get alerted when new OTC DEFICIENCY trials appear

Experimental therapy for rare metabolic disease shows early promise